BridgeMD
New treatment option for Hypertension
Official title Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
ClinicalTrials.gov ID: NCT07099677
What this study is testing
What is Beta Blocker?
Beta Blocker is an investigational medicine, given as an once-daily, being studied as a potential treatment for hypertension.
Also referred to as Beta-Adrenergic Receptor Blocker, β-blocker.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare the short-term effects of three commonly prescribed antihypertensive drug classes (beta-blockers, ACE inhibitors, and calcium channel blockers) on postural balance and fall risk in adults with newly diagnosed primary hypertension. The main questions it aims to answer are: Do different antihypertensive drugs affect objective balance performance and fall risk?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Aged between 18 and 75 years
- Newly diagnosed with primary hypertension
- No prior use of antihypertensive medication
- No history of neurological, vestibular, orthopedic, or psychiatric conditions affecting balance
- Able to walk independently without assistive devices
You likely can't join if
- Secondary hypertension
- Known diagnosis of vestibular disorders (e.g., BPPV, Ménière's disease)
- Use of medications that may affect balance (e.g., sedatives, psychotropic drugs)
- History of falls due to trauma unrelated to balance
- Cognitive impairment preventing proper test participation
- Inability to complete the assessments at follow-up timepoints (2nd and 4th week)
See the full eligibility criteria
- Aged between 18 and 75 years
- Newly diagnosed with primary hypertension
- No prior use of antihypertensive medication
- No history of neurological, vestibular, orthopedic, or psychiatric conditions affecting balance
- Able to walk independently without assistive devices
- Provided written informed consent to participate in the study
- Secondary hypertension
- Known diagnosis of vestibular disorders (e.g., BPPV, Ménière's disease)
- Use of medications that may affect balance (e.g., sedatives, psychotropic drugs)
- History of falls due to trauma unrelated to balance
- Cognitive impairment preventing proper test participation
- Inability to complete the assessments at follow-up timepoints (2nd and 4th week)
The study team makes the final eligibility decision.
Where it's taking place
- Bolu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bolu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.